Singer, J., Weichselbaumer, M., Stockner, T., Mechtcheriakova, D., Sobanov, Y., Bajna, E., . . . Jensen-Jarolim, E. (2012). Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. Pergamon Press.
Chicago-стиль цитированияSinger, Josef, et al. Comparative Oncology: ErbB-1 and ErbB-2 Homologues in Canine Cancer Are Susceptible to Cetuximab and Trastuzumab Targeting. Pergamon Press, 2012.
MLA-цитированиеSinger, Josef, et al. Comparative Oncology: ErbB-1 and ErbB-2 Homologues in Canine Cancer Are Susceptible to Cetuximab and Trastuzumab Targeting. Pergamon Press, 2012.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.